These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2917340)

  • 1. Stabilization and quantitative analysis of fecapentaenes in human feces, using synthetic fecapentaene-12.
    Kleinjans JC; Pluijmen MH; Hageman GJ; Verhagen H
    Cancer Lett; 1989 Jan; 44(1):33-7. PubMed ID: 2917340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and quantitative distribution of eight analogues of naturally occurring fecapentaenes in human feces by high-performance liquid chromatography.
    de Kok TM; ten Hoor F; Kleinjans JC
    Carcinogenesis; 1991 Feb; 12(2):199-205. PubMed ID: 1995185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative HPLC analysis of the level of fecapentaenes and their precursors in human feces by a chemical conversion method.
    Kivits GA; de Boer BC; Nugteren DH; van der Steeg M; Vertegaal LB; van der Gen A
    J Nat Prod; 1990; 53(1):42-9. PubMed ID: 2348203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecapentaene concentration and mutagenicity in 718 North American stool samples.
    Schiffman MH; Van Tassell RL; Andrews AW; Wacholder S; Daniel J; Robinson A; Smith L; Nair PP; Wilkins TD
    Mutat Res; 1989 Apr; 222(4):351-7. PubMed ID: 2649794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecapentaene excretion: aspects of excretion in newborn infants, children, and adult normal subjects and in adults maintained on total parenteral nutrition.
    Block JB; Dietrich MF; Leake R; Laidlaw SA; Vinton NE; Kopple JD
    Am J Clin Nutr; 1990 Apr; 51(4):698-704. PubMed ID: 2108580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecapentaenes and their precursors throughout the bowel--results of an autopsy study.
    Schiffman MH; Bitterman P; Viciana AL; Schairer C; Russell L; Van Tassell RL; Wilkins TD
    Mutat Res; 1988 May; 208(1):9-15. PubMed ID: 3367931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case-control study of colorectal cancer and fecapentaene excretion.
    Schiffman MH; Van Tassell RL; Robinson A; Smith L; Daniel J; Hoover RN; Weil R; Rosenthal J; Nair PP; Schwartz S
    Cancer Res; 1989 Mar; 49(5):1322-6. PubMed ID: 2917361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecapentaene excretion and fecal mutagenicity in relation to nutrient intake and fecal parameters in humans on omnivorous and vegetarian diets.
    de Kok TM; van Faassen A; Bausch-Goldbohm RA; ten Hoor F; Kleinjans JC
    Cancer Lett; 1992 Feb; 62(1):11-21. PubMed ID: 1540928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On distribution of different fecapentaenes, the fecal mutagens, in the human population.
    Baptista J; Bruce WR; Gupta I; Krepinsky JJ; van Tassell RL; Wilkins TD
    Cancer Lett; 1984 Apr; 22(3):299-303. PubMed ID: 6713371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro study on the effects of fecal composition on fecapentaene kinetics in the large bowel.
    de Kok TM; van Iersel ML; ten Hoor F; Kleinjans JC
    Mutat Res; 1993 Jun; 302(2):103-8. PubMed ID: 7684504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of fecapentaenes, the mutagens of bacterial origin isolated from human feces.
    Gupta I; Baptista J; Bruce WR; Che CT; Furrer R; Gingerich JS; Grey AA; Marai L; Yates P; Krepinsky JJ
    Biochemistry; 1983 Jan; 22(2):241-5. PubMed ID: 6824628
    [No Abstract]   [Full Text] [Related]  

  • 12. Case-control study of colorectal cancer and fecal mutagenicity.
    Schiffman MH; Andrews AW; Van Tassell RL; Smith L; Daniel J; Robinson A; Hoover RN; Rosenthal J; Weil R; Nair PP
    Cancer Res; 1989 Jun; 49(12):3420-4. PubMed ID: 2655896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of changes in amount and type of dietary fat to fecapentaenes in premenopausal women.
    Taylor PR; Schiffman MH; Jones DY; Judd J; Schatzkin A; Nair PP; Van Tassell R; Block G
    Mutat Res; 1988 Sep; 206(1):3-9. PubMed ID: 3412371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chromatographic-isotopic dilution analysis of fecapentaenes in human feces.
    Peters JH; Nolen HW; Gordon GR; Bradford WW; Bupp JE; Reist EJ
    J Chromatogr; 1989 Mar; 488(2):301-13. PubMed ID: 2663902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory and epidemiologic studies of fecapentaenes.
    Povey AC; Schiffman M; Taffe BG; Harris CC
    Mutat Res; 1991; 259(3-4):387-97. PubMed ID: 2017218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecapentaene-12 causes DNA damage and mutations in human cells.
    Plummer SM; Grafstrom RC; Yang LL; Curren RD; Linnainmaa K; Harris CC
    Carcinogenesis; 1986 Sep; 7(9):1607-9. PubMed ID: 3742732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bacterial mutagenicity of synthetic all-trans fecapentaene-12 changes when assayed under anaerobic conditions.
    Venitt S; Bosworth D
    Mutagenesis; 1988 Mar; 3(2):169-73. PubMed ID: 3288841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal mutagen fecapentaene-12 damages mammalian colon epithelial DNA.
    Hinzman MJ; Novotny C; Ullah A; Shamsuddin AM
    Carcinogenesis; 1987 Oct; 8(10):1475-9. PubMed ID: 3652384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of the genotoxicity of fecapentaenes.
    Nair PP; Shami S; Sainz E; Judd JT; Taylor PR; Schatzkin A
    Mutat Res; 1991 Jun; 260(2):153-7. PubMed ID: 1904547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the stereochemistry of fecapentaene-12.
    Kingston DG; Piccariello T; Duh CY; Govindan SV; Wilkins TD; van Tassell RL; Van der Gen A; De Wit PP; Van der Steeg M
    J Nat Prod; 1988; 51(1):176-9. PubMed ID: 3373225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.